Stock page
Cognos Therapeutics Holdings Inc (COGN)
Cognos Therapeutics Holdings Inc is a medical technology company focused on creating advanced implantable pump devices for neurological and oncological indications. Its goal is to develop devices that adjust the course of therapeutics for the treatment and mitigation of disease models where current technology does not provide an effective solution. Its flagship product, the SINNAIS Implantable Smart Pump (SINNAIS), is the result of over a decade and a half of research and development in the field of implantable drug delivery pumps. SINNAIS represents a platform designed for the future, incorporating microelectronics, communication capabilities, and embedded programmable parameters in its architecture.
Quote snapshot
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|